SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
- 31
PR Newswire
NEW YORK, May 6, 2024
NEW YORK, May 6, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. ("Zymeworks" or the "Company") (NASDAQ: ZYME). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980
The investigation concerns whether Zymeworks and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On April 1, 2024, Zymeworks disclosed that it had removed Christopher Astle ("Astle") from the positions of Senior Vice President ("SVP") and Chief Financial Officer ("CFO"), effective immediately. Notably, although Zymeworks indicated that it had appointed current President and Chief Executive Officer Kenneth Galbraith as Interim CFO and had initiated a search for a new CFO, the Company failed to provide any reasoning for Astle's removal as SVP and CFO.
On this news, Zymeworks's stock price fell $0.64 per share, or 6.08%, to close at $9.88 per share on April 1, 2024.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-zymeworks-inc---zyme-302137390.html
SOURCE Pomerantz LLP
![](https://rt.prnewswire.com/rt.gif?NewsItemId=DC06953&Transmission_Id=202405061938PR_NEWS_USPR_____DC06953&DateId=20240506)
PR Newswire est une agence de presse américaine, située à New York spécialisée dans la publication de communiqués de presse.
- NOMINATIONS AU SEIN DU COMITÉ DE DIRECTION D'ATEME
- GAUMONT : Informations relatives au nombre total de droits de vote et d'actions du capital social au 31 mai 2024
- First Phosphate accueille avec satisfaction l'ajout du phosphore à la liste des minéraux critiques du Canada
- First Phosphate accueille avec satisfaction l'ajout du phosphore à la liste des minéraux critiques du Canada
- Avis de convocation à l'Assemblée Générale Mixte du 25 juin 2024 (Affiches Parisiennes)
- PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 3 JUIN 2024 au 7 JUIN 2024